In addition to its specific indications for Bipolar I Disorder, ABILIFY is indicated for the treatment of schizophrenia including maintaining stability in adults who had been symptomatically stable on other antipsychotic medications for periods of three months or longer and observed for relapse during a period of up to 26 weeks. Physicians who elect to use ABILIFY for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual.
Somerset Pharmaceuticals, Inc. (Somerset) is a proprietary research and development pharmaceutical company located in Tampa, Florida. Somerset markets Eldepryl® in capsule form for the treatment of patients with late-stage Parkinson's Disease. Somerset is currently engaged in the clinical development of a selegiline transdermal system for the treatment of several indications, including Alzheimer's Disease, Depression and Parkinson's Disease. Somerset was formed in 1986 and joined the Mylan family in 1988.
Pfizer Inc is a company that operates in the Pharmaceuticals industry. It employs 1-5 people and has $1M-$5M of revenue. The company is headquartered in Morrisville, North Carolina.